Sonnet BioTherapeutics Holdings Inc (SONN) last month performance of -41.69% certainly makes it a sizzling prospect
Witnessing the stock’s movement on the chart, on Wednesday, Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) had a quiet start as it plunged -5.05% to $2.63,